PUBLICATIONS
Articles
New publication about the treatment of triple-class refractory multiple myeloma in Spain
We are very pleased to share the latest publication for which OMAKASE is a coauthor. A study to determine the value contribution of belantamab mafodotin (Belamaf) for the treatment of [...]
New evidence about risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain
We are proud to publish with national experts in infectious diseases and microbiology. Full text available here: Ferrer R. et al. Revista Española de Quimioterapia_29_04_2021 [...]
Clinical benefit, health priorities and economic evaluation lessons learnt with COVID-19 vaccine
Letter from Dr. Xavier Badia, EDS Director. [...]
Chronic liver disease-associated severe thrombocytopenia in Spain through Delphi method
Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts Avaliable at: https://www.reed.es/ArticuloFicha.aspx?id=4799&hst=0&idR= [...]
Analysis of Orphan Drugs P&R criteria in Spain (2003-2019)
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019 Ava [...]
Acute myeloid leukaemia in Spain through Delphi method
Current status of acute myeloid leukaemia in Spain: Results from a Delphi study on its epidemiology, disease management and unmet clinical needs Avaliable at: https://www.elsevier.es/e [...]